Search

everythinglearnresearchcommunity

for

Search:↓

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

Trichoscopy and histopathology can help identify post-COVID-19 hair loss.

Most severe COVID-19 patients had hair loss, suggesting a possible link.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

During the COVID-19 pandemic, a clinic in Turkey saw fewer patients but more cases of certain skin conditions, possibly linked to the virus and stress.

Healthcare workers with COVID-19 reported more long-term symptoms, and physical activity may help reduce some of these symptoms.

Searches for acne, hair loss, and eczema increased during COVID-19, while searches for other skin issues decreased.

Healthcare workers with a positive COVID-19 test were more likely to report long-COVID symptoms.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

Older male COVID-19 patients are more likely to experience hair loss.

Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.

Hair loss doesn't affect COVID-19 severity.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Red stripes on nails and hair loss may occur after COVID-19.

During COVID-19, Iraqi women saw more hair loss and skin issues like acne due to stress, masks, and hygiene habits.

Higher oxidative stress markers are linked to hair loss in post-COVID-19 patients.

COVID-19 infection or vaccination may influence the development of alopecia areata, a type of hair loss.

Skin problems like rashes and hair loss can help diagnose and predict COVID-19.

COVID-19 can cause various skin issues, like rashes and hair loss, which help in early diagnosis.

Hair loss may be a delayed side effect of Multisystem Inflammatory Syndrome in children after COVID-19.

Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Post-COVID-19 patients often experience musculoskeletal issues, fitness decline, behavioral changes, chest pain, cough, hair loss, and nervous system problems.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

The Gabrin sign may help identify COVID-19 patients at high risk who also have hair loss due to male hormones.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

COVID-19 may cause temporary hair loss in some people.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.